Local Anesthetic Infusion and Sternotomy (CARDIODOLAL)
Primary Purpose
Hyperalgesia, Pain
Status
Terminated
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
Local anesthetic (Ropivacaine)
Saline
Sponsored by
About this trial
This is an interventional treatment trial for Hyperalgesia focused on measuring Sternotomy, Postoperative hyperalgesia, Intralesional anesthetic infusion, Ropivacaïne, Chronic, Postoperative pain, Cardiac surgery, Sternum, Cardiac surgical procedures
Eligibility Criteria
Inclusion Criteria:
- Patients aged from 50 to 75 years old
- ASA score : 1-3
Cardiac surgery with median sternotomy for:
- single valve replacement, Bentall, Bahnson, Tyrone David procedure
- single or multiple Cardiac Artery Bypass Grafting (CABG)
- combined surgery (valve replacement + CABG)
- without predicted risk of postoperative complication
- Informed consent obtained from the patient
- Patient beneficiating of social insurance
Exclusion Criteria:
- patient refusal to participate in the study
- Drug or alcohol abuse history
- Analgesic or opioid consumption within the 12 hours preceding the surgery
- Chronic use of analgesic drugs or history of chronic pain
- Disability to understand morphine PCA use
- Allergy to ropivacaine or other local anaesthesia
- Patient treated by fluvoxamine or enoxamine
- Patient suffering for liver insufficiency (child score >A)
- Patient with major preoperative hypovolemia
Sites / Locations
- Département d'Anesthésie-Réanimation II - Hôpital cardiologique - Groupe Hospitalier Sud, CHU de Bordeaux - 4, Av de Magellan
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
1
2
Arm Description
48h postoperative infusion of ropivacaine
48h postoperative infusion of NaCl.
Outcomes
Primary Outcome Measures
hyperalgesia area size around the cicatrix
Secondary Outcome Measures
Peroperative monitoring datas
Dynamic hyperalgesia
Static hyperalgesia
Ropivacaine plasmatic concentration
Full Information
NCT ID
NCT00802048
First Posted
December 3, 2008
Last Updated
December 12, 2011
Sponsor
University Hospital, Bordeaux
1. Study Identification
Unique Protocol Identification Number
NCT00802048
Brief Title
Local Anesthetic Infusion and Sternotomy
Acronym
CARDIODOLAL
Official Title
Study of Effectiveness of a Ropivacaïne Continuous Sternal Infusion to Reduce Postoperative Hyperalgesia Induced by Sternotomy After Cardiac Surgery
Study Type
Interventional
2. Study Status
Record Verification Date
December 2011
Overall Recruitment Status
Terminated
Study Start Date
February 2009 (undefined)
Primary Completion Date
January 2010 (Actual)
Study Completion Date
August 2010 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Bordeaux
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Cardiac surgery often induces acute postoperative pain and moreover chronic dysesthesia frequently occur long-term after sternotomy. The high doses of intraoperative opioïds are well known to enhance postoperative hyperalgesia (HA) and a perioperative local anesthetic agent infusion is one of the therapeutic strategies used to limit this phenomena. The aim of this study was to evaluate the effectiveness of a continuous Ropivacaïne sternal infusion compared with a saline serum infusion to limit postoperative HA, pain and morphine consumption (M) after sternotomy in cardiac surgery.
This strategy could lead to lower postoperative morphine consumption and opioïd induced hyperalgesia.
Detailed Description
Principal Objective: comparison of peri-incisionnal dynamic hyperalgesia extend evaluated by Von Frey filament during the first postoperative week between the two groups.
Secondary Objective: comparison of peri-incisionnal static hyperalgesia (pain threshold) extend evaluated by Von Frey filament, postoperative pain scores, morphine consumption, hemodynamic and respiratory parameters during the first postoperative week and incidence of chronic pain and dysesthesia at six month between the two groups. Ropivacaïne plasmatic concentration will be monitored, during infusion.
Study design : monocentric, double blind randomized clinical trial comparing two groups of patients with a same intraoperative anesthetic management :
Group 1: Ropivacaïne infiltration before skin incision followed by a 48 hours Ropivacaïne continuous infusion after surgery through a sternal fenestrated catheter
Group 2: same protocol with pre and postoperative saline infusion
Postoperative pain management is identical in the two groups based upon a Morphine sulfate PCA pump for the first 48 hours.
• Number of subjects : 40 patients, 20 in each group
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hyperalgesia, Pain
Keywords
Sternotomy, Postoperative hyperalgesia, Intralesional anesthetic infusion, Ropivacaïne, Chronic, Postoperative pain, Cardiac surgery, Sternum, Cardiac surgical procedures
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
21 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Experimental
Arm Description
48h postoperative infusion of ropivacaine
Arm Title
2
Arm Type
Placebo Comparator
Arm Description
48h postoperative infusion of NaCl.
Intervention Type
Drug
Intervention Name(s)
Local anesthetic (Ropivacaine)
Intervention Description
Local anesthetic infusion
Intervention Type
Drug
Intervention Name(s)
Saline
Intervention Description
Saline serum infusion
Primary Outcome Measure Information:
Title
hyperalgesia area size around the cicatrix
Time Frame
24h after surgery
Secondary Outcome Measure Information:
Title
Peroperative monitoring datas
Time Frame
Peroperative
Title
Dynamic hyperalgesia
Time Frame
Day 2, 3 and 6
Title
Static hyperalgesia
Time Frame
Day 1, 2, 3 and 6
Title
Ropivacaine plasmatic concentration
Time Frame
24h and 48h
10. Eligibility
Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients aged from 50 to 75 years old
ASA score : 1-3
Cardiac surgery with median sternotomy for:
single valve replacement, Bentall, Bahnson, Tyrone David procedure
single or multiple Cardiac Artery Bypass Grafting (CABG)
combined surgery (valve replacement + CABG)
without predicted risk of postoperative complication
Informed consent obtained from the patient
Patient beneficiating of social insurance
Exclusion Criteria:
patient refusal to participate in the study
Drug or alcohol abuse history
Analgesic or opioid consumption within the 12 hours preceding the surgery
Chronic use of analgesic drugs or history of chronic pain
Disability to understand morphine PCA use
Allergy to ropivacaine or other local anaesthesia
Patient treated by fluvoxamine or enoxamine
Patient suffering for liver insufficiency (child score >A)
Patient with major preoperative hypovolemia
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Olivier POUQUET, Dr
Organizational Affiliation
University Hospital, Bordeaux
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Antoine BENARD, Dr
Organizational Affiliation
University Hospital, Bordeaux
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Mathieu LAFARGUE, MD
Organizational Affiliation
University Hospital, Bordeaux
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Alexandre OUATTARA, MD
Organizational Affiliation
University Hospital, Bordeaux
Official's Role
Principal Investigator
Facility Information:
Facility Name
Département d'Anesthésie-Réanimation II - Hôpital cardiologique - Groupe Hospitalier Sud, CHU de Bordeaux - 4, Av de Magellan
City
Pessac
ZIP/Postal Code
33604
Country
France
12. IPD Sharing Statement
Learn more about this trial
Local Anesthetic Infusion and Sternotomy
We'll reach out to this number within 24 hrs